Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Technical Guide: EDC.HCl (3-(ethyliminomethylideneamino)-N,N

    2026-06-22

    EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride): Technical Workflow Guide

    What This Product Solves

    Efficient amide bond formation is a foundational step in peptide synthesis, bioconjugation, and nucleotide coupling protocols. EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride, CAS 25952-53-8) addresses the need for a water-soluble carbodiimide reagent that can activate carboxyl groups in aqueous media, facilitating rapid and direct coupling to primary amines. The reagent is routinely used for the synthesis of peptides, protein labeling, oligonucleotide modification, and esterification, where it enables the formation of stable amide or ester linkages without introducing non-aqueous solvents or excessive side products. The product is intended exclusively for in vitro workflows; it should not be used in vivo or in clinical protocols due to the absence of supporting data. For further detail on in vitro scope and technical guidance, see related articles such as Technical Protocol Guidance and Practical Technical Guide, both of which elaborate on best practices for peptide synthesis and bioconjugation reagent use.

    Protocol Parameters

    • Stock solution solubility | ≥39 mg/mL in water, ≥19.2 mg/mL in DMSO, ≥39.6 mg/mL in ethanol | Applicability: Preparation of concentrated working solutions for peptide synthesis, bioconjugation, or nucleotide synthesis | Rationale: High solubility in common solvents enables flexibility in protocol design and minimizes precipitation risk | Product dossier
    • Storage conditions | Desiccated at -20°C (solid); avoid long-term storage of solutions | Applicability: Preservation of reagent stability and prevention of hydrolysis prior to use | Rationale: Carbodiimides are moisture-sensitive and degrade in solution; solid-state storage extends shelf life | Product dossier
    • Spectrophotometric monitoring | Quantitative monitoring feasible | Applicability: Real-time tracking of EDC.HCl consumption or byproduct formation during coupling reactions | Rationale: Enables quantitative assessment of coupling efficiency and end-point determination | Product dossier
    • Recommended reaction temperature | 20–25°C (room temperature) | Applicability: Standard coupling reactions in peptide synthesis and bioconjugation | Rationale: Carbodiimide-mediated reactions typically proceed efficiently at ambient temperatures; higher temperatures may increase byproduct formation | Workflow recommendation

    Workflow Setup and QC Checklist

    For optimal results in peptide synthesis or bioconjugation using EDC.HCl, follow these procedural steps and checkpoints:

    • Reagent Handling: Prepare EDC.HCl solutions immediately prior to use to minimize hydrolysis. Store all unused solid reagent tightly sealed under desiccation at -20°C.
    • Buffer Selection: Use buffers that do not contain primary amines (e.g., MES, phosphate) to prevent reagent quenching. Avoid Tris or glycine in coupling reactions.
    • pH Control: Adjust reaction pH to 4.5–7.5 for optimal carbodiimide activity, depending on nucleophile and substrate; confirm with pH meter prior to reagent addition.
    • QC for Completion: Monitor reaction progress by spectrophotometric analysis where feasible, or by analytical HPLC of the reaction mixture to verify amide or ester formation.
    • Byproduct Removal: Remove urea byproduct by dialysis, size-exclusion chromatography, or repeated buffer exchange, especially in sensitive bioconjugation protocols.

    Common Failure Modes and Fixes

    • Incomplete Coupling: May result from hydrolyzed or degraded EDC.HCl. Always use freshly prepared solutions and avoid prolonged exposure to moisture. Confirm substrate and reagent concentrations.
    • Precipitation During Reaction: Can occur if EDC.HCl or substrates are insufficiently soluble. Ensure concentrations do not exceed solubility limits; use DMSO or ethanol as co-solvents within protocol tolerances.
    • Unwanted Side Products: Overactivation or use of impure buffers may cause N-acylurea or O-acylisourea formation. Use high-purity reagents, control reaction times, and adjust pH as needed.
    • Buffer Interference: Buffers containing primary amines (e.g., Tris, glycine) quench EDC.HCl. Substitute with non-nucleophilic buffers.
    • Insufficient Byproduct Removal: Residual urea can interfere with downstream applications. Employ adequate purification steps post-reaction.

    Scope and Limitations

    EDC.HCl is validated for in vitro peptide synthesis, protein labeling, nucleotide coupling, esterification, and lactonization workflows. It is not suitable for in vivo or clinical research, as no such data are available. The reagent's efficacy is dependent on reaction pH, substrate solubility, and exclusion of competing nucleophiles in buffer systems. For further technical boundaries and recommended applications, consult product information and review internal technical guides where available.

    Conclusion

    EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) offers a practical and well-characterized solution for efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide synthesis workflows. Its water solubility and compatibility with aqueous buffers provide significant workflow advantages, provided that protocols adhere to best storage and handling practices. For detailed product specifications and ordering, refer to EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) at APExBIO.